Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Microbiology and Immunology
Published in: Medical Microbiology and Immunology 5/2020

01-10-2020 | Gonococcus | Correction

Correction to: Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century

Authors: Beata Młynarczyk-Bonikowska, Anna Majewska, Magdalena Malejczyk, Grażyna Młynarczyk, Sławomir Majewski

Published in: Medical Microbiology and Immunology | Issue 5/2020

Login to get access

Excerpt

The article “Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century”, written by Beata Młynarczyk‑Bonikowska, Anna Majewska, Magdalena Malejczyk, Grażyna Młynarczyk, Sławomir Majewski was originally published electronically on the publisher’s internet portal (currently SpringerLink) on December 04, 2019 without open access. …
Metadata
Title
Correction to: Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century
Authors
Beata Młynarczyk-Bonikowska
Anna Majewska
Magdalena Malejczyk
Grażyna Młynarczyk
Sławomir Majewski
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Keyword
Gonococcus
Published in
Medical Microbiology and Immunology / Issue 5/2020
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-020-00669-z

Other articles of this Issue 5/2020

Medical Microbiology and Immunology 5/2020 Go to the issue

Original Investigation

Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+ Aspergillus fumigatus specific T-cell quantification

Correction

Correction to: Tetraspanins in mammalian reproduction: spermatozoa, oocytes and embryos

Original Investigation

Evaluation of Salmonella Typhi antigen YncE alongside HlyE for the detection of typhoid fever and its carriers

Correction

Correction to: A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis

Original Investigation

The effect of KIR and HLA polymorphisms on dengue infection and disease severity in northeastern Thais

Original Investigation

Association of serum C-reactive protein level and polymorphisms with susceptibility to dengue infection and severe clinical outcome among eastern Indian patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits